Magnera (MAGN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 May, 2026Executive summary
Net sales for the quarter were $796 million, with adjusted EBITDA of $90 million and free cash flow of $73 million, reflecting stable performance amid macroeconomic and weather-related challenges.
$36 million in debt repayments were made, enabled by strong free cash flow and a focus on operational excellence.
Winter storms caused temporary shutdowns at North American plants, but no significant damage occurred and most setbacks are expected to be recouped in the second half.
The war in the Middle East and global macroeconomic uncertainty increased raw material and supply chain costs, impacting operational expenses.
Strategic investments in sustainability and efficiency projects continue, with new initiatives at Gernsbach, Lydney, and Dombühl facilities.
Financial highlights
Net sales declined 3% year-over-year to $796 million, with operating income rising to $17 million from $4 million in the prior year quarter.
Adjusted EBITDA was $90 million, up 1% year-over-year, as internal gains were offset by external headwinds.
Free cash flow for the quarter was $73 million, with a trailing 12-month adjusted free cash flow yield exceeding 40%.
Net loss for the quarter was $18 million, or $(0.50) per share, improved from a $41 million loss, or $(1.15) per share, in the prior year.
Americas revenue declined to $437 million, Rest of World revenue was $359 million; Rest of World adjusted EBITDA increased 19% to $32 million, while Americas adjusted EBITDA declined 9% to $58 million.
Outlook and guidance
Full-year adjusted EBITDA guidance remains $380–$410 million, with free cash flow of $90–$110 million and cash from operations projected at $170–$190 million.
Management reaffirmed guidance, expecting headwinds in Q3 due to inflation and supply chain volatility, with recovery anticipated in Q4.
Capex outlook is 2–3% of sales in the near term, with no near-term debt maturities.
Focus remains on deleveraging to a leverage target of approximately 3.0x.
Latest events from Magnera
- 2026 guidance targets EBITDA growth, debt reduction, and expansion in key nonwoven markets.MAGN
Sidoti March Small-Cap Virtual Conference18 Mar 2026 - All proposals passed, directors elected, and no shareholder questions were raised.MAGN
AGM 20269 Mar 2026 - Net sales up 13% to $792M, adjusted EBITDA up 11%, and 2026 guidance reaffirmed.MAGN
Q1 20265 Feb 2026 - Proxy covers director elections, auditor ratification, executive pay, and strong ESG focus.MAGN
Proxy filing14 Jan 2026 - Votes on directors, auditor ratification, and executive pay are set for the 2026 meeting.MAGN
Proxy filing14 Jan 2026 - Q1 sales rose 35% to $702M post-merger, with EBITDA up 8% and widened losses from integration costs.MAGN
Q1 202523 Dec 2025 - Strong Q4, raised 2026 outlook, and innovation drive global growth and operational excellence.MAGN
BofA Securities Leveraged Finance Conference 20253 Dec 2025 - Net sales hit $839M, EBITDA $91M; merger and cost initiatives offset market softness.MAGN
Q3 202523 Nov 2025 - Q2 sales up 48% to $824M on merger, but net loss and lower EBITDA guidance issued.MAGN
Q2 202521 Nov 2025